MMMarek Michalski

Marek Michalski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marek Michalski has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • Marlena Brzozowa-Zasada

    Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland

    16 shared publications
  • Romuald Wojnicz

    Department of Histology and Cell Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland

    11 shared publications
  • Adam Piecuch

    Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland

    8 shared publications
  • Natalia Matysiak

    Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland

    8 shared publications
  • Łukasz Mielańczyk

    Department of Histology and Cell Pathology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland

    7 shared publications
  • Adam Piecuch

    A Department of Histology and Embryology , School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia , Katowice , Poland

    5 shared publications

Latest Publications

  • Open Access

    Effects of a 21-Day Individual Rehabilitation Exercise Training Program on CRP, Cholesterol, aHSG, GDF-15, and IGF-1 Levels in Patients After Hip or Knee Replacement Surgery

    by Jakub Poloczek, Anna Michalik, Katarzyna Michalczyk, Elżbieta Chełmecka, Marek Michalski, Bartosz Bogielski, Dariusz Gach, Mateusz Stojko, Michał Kukla, Mateusz Marcinek, et al.

    Background/Objectives: Osteoarthritis (OA) is the most prevalent degenerative joint disease and a major cause of disability. In advanced stages, joint arthroplasty remains the primary treatment, yet postoperative rehabilitation plays a key role in recovery and systemic metabolic regulation. This study investigated the molecular effects of a 21-day individualized rehabilitation program in 42 patients (26 males and 16 females) following hip or knee arthroplasty. Methods: Functional capacity was evaluated by the six-minute walk test (6MWT), and serum biomarkers, including C-reactive protein (CRP), total cholesterol, α2-Heremans-Schmid glycoprotein (aHSG/fetuin-A), growth differentiation factor-15 (GDF-15), and insulin-like growth factor-1 (IGF-1), were analyzed before and after rehabilitation. Results: Unadjusted paired analyses showed a significant increase in 6MWT distance (72.2 ± 30.6 m; p < 0.001), together with reductions in body mass and BMI. Significant pre–post differences were also observed for all analyzed biomarkers, comprising decreases in CRP, total cholesterol, aHSG/fetuin-A, and GDF-15 and an increase in IGF-1 (all p < 0.001). In the additional multivariable repeated-measures models adjusted for age, sex, baseline BMI, and time since surgery, the independent main effect of time did not reach statistical significance for any of the principal outcomes (all p > 0.05; lowest p = 0.100 for 6MWT). Conclusions: Significant unadjusted within-participant differences in functional performance and circulating inflammatory and metabolic biomarkers were observed over the 21-day rehabilitation period. However, the adjusted models did not provide sufficient statistical evidence that these differences represented an independent main effect of time. Given the limited sample size and the absence of a concurrent control group, the findings should be interpreted as temporal pre–post associations rather than as evidence of an independent causal effect of rehabilitation.

  • Open Access

    Clinicopathological Significance of SCD Expression in Colon Adenocarcinoma: Association with Histological Grade and Exploratory Assessment in Relation to PCNA

    by Jerzy Z. Piecuch, Adam Piecuch, Marek Michalski, Magdalena Rynkiewicz, Natalia Matysiak, Magdalena Onyszczuk, Marlena Brzozowa-Zasada

    Background/Objectives: Colon adenocarcinoma is a heterogeneous disease, and tumours of similar pathological stage may differ in their metabolic and proliferative characteristics. Stearoyl-CoA desaturase (SCD) is involved in lipid metabolic reprogramming and may reflect aspects of tumour biology. The main goal of this study was to analyse SCD expression and its associations with clinicopathological factors, particularly focusing on histological grade. The relationship between SCD and proliferating cell nuclear antigen (PCNA) was evaluated as a secondary objective. Methods: Public TCGA/UALCAN and CPTAC/UALCAN data were examined as supportive transcriptomic and proteomic observations. Immunohistochemical SCD and PCNA expression was assessed in 113 patients with colon adenocarcinoma, and SCD localisation was additionally examined by qualitative immunogold electron microscopy. Standardised SCD and PCNA scores were combined with equal weighting to generate a secondary exploratory z-score. Associations with clinicopathological characteristics were assessed using appropriate univariable analyses, while the relationship between SCD and PCNA and the potential incremental contribution of SCD beyond PCNA were examined using correlation and exploratory regression-based analyses. ROC analyses were used only as exploratory descriptions of statistical separation between predefined clinicopathological groups. Results: Observations from supportive public databases indicated that SCD expression was higher in tumour tissue compared to normal tissue at both the transcriptomic and proteomic levels. In the institutional cohort, SCD expression was elevated in tumour tissue relative to matched non-neoplastic mucosa and was associated primarily with histological grade but not with nodal status or pathological stage. SCD showed a modest positive correlation with PCNA. The secondary exploratory combined SCD–PCNA score was associated with histological grade and with nodal status but did not outperform PCNA alone. Adding SCD to PCNA provided only limited incremental information for G3 histology and no incremental value for nodal involvement. Conclusions: SCD is a tumour-associated metabolic marker in colon adenocarcinoma, with its strongest association observed for histological grade. The combined score should not be interpreted as a biological entity or superior biomarker.

  • Open Access

    Association of B3GNT3 Expression with Tumour Stage and Lymph Node Metastasis in Colon Adenocarcinoma

    by Adam Piecuch, Jerzy Z. Piecuch, Karolina Bajdak-Rusinek, Marek Michalski, Natalia Matysiak, Marlena Brzozowa-Zasada

    Aberrant glycosylation contributes to tumour progression and metastatic dissemination. Beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3) is involved in poly-N-acetyllactosamine synthesis, but its role in colon adenocarcinoma remains insufficiently characterised. This retrospective single-centre study evaluated B3GNT3 expression and its association with clinicopathological parameters using TCGA and CPTAC data, immunohistochemistry in 97 colon adenocarcinomas, Western blot analysis, and transmission electron microscopy. TCGA analysis showed no significant differences in B3GNT3 mRNA expression between normal and tumour tissues. In contrast, CPTAC, immunohistochemistry, and Western blot analyses demonstrated increased B3GNT3 protein expression in tumour tissue compared with non-neoplastic mucosa. Immunohistochemical expression was assessed semi-quantitatively using the immunoreactive score (IRS). Lower B3GNT3 expression was associated with advanced stage and node-positive status. Because pathological stage and lymph node status are interrelated clinicopathological variables in colon adenocarcinoma, these findings were interpreted as partially overlapping associations rather than independent biological endpoints. Exploratory ROC and logistic regression analyses supported these cohort-level associations; however, the ROC-derived IRS cut-off was not externally validated, and regression models were interpreted cautiously. TEM/immunogold analysis supported Golgi/secretory-pathway localisation but was descriptive. Overall, B3GNT3 expression was associated with clinicopathological features in this retrospective cohort.

  • Open Access

    Glutaredoxin 2 Protein (Grx2) as an Independent Prognostic Factor Associated with the Survival of Colon Adenocarcinoma Patients

    by Marlena Brzozowa-Zasada, Adam Piecuch, Karolina Bajdak-Rusinek, Karolina Gołąbek, Marek Michalski, Kamil Janelt, Natalia Matysiak

    Glutaredoxin 2 (Grx2; Glrx2) is a glutathione-dependent oxidoreductase located in mitochondria, which is central to the regulation of glutathione homeostasis and mitochondrial redox, and plays a crucial role in highly metabolic tissues. In response to mitochondrial redox signals and oxidative stress, Grx2 can catalyze the oxidation and S-glutathionylation of membrane-bound thiol proteins in mitochondria. Therefore, it can have a significant impact on cancer development. To investigate this further, we performed an immunohistochemical analysis of Grx2 protein expression in colon adenocarcinoma samples collected from patients with primary colon adenocarcinoma (stage I and II) and patients with metastasis to regional lymph nodes (stage III). The results of our study revealed a significant relationship between the immunohistochemical expression of Grx2 and tumor histological grade, depth of invasion, regional lymph node involvement, angioinvasion, staging, and PCNA immunohistochemical expression. It was found that 87% of patients with stage I had high levels of Grx2 expression. In contrast, only 33% of patients with stage II and 1% of patients with stage III had high levels of Grx2 expression. Moreover, the multivariate analysis revealed that the immunohistochemical expression of Grx2 protein apart from the grade of tumor differentiation was an independent prognostic factors for the survival of patients with colon adenocarcinoma. Studies analyzing Grx2 levels in patients’ blood confirmed that the highest levels of serum Grx2 protein was also found in stage I patients, which was reflected in the survival curves. A higher level of Grx2 in the serum has been associated with a more favorable outcome. These results were supported by in vitro analysis conducted on colorectal cancer cell lines that corresponded to stages I, II, and III of colorectal cancer, using qRT-PCR and Western Blot.


  • Open Access

    A Prognostic Activity of Glutaredoxin 1 Protein (Grx1) in Colon Cancer

    by Marlena Brzozowa-Zasada, Adam Piecuch, Karolina Bajdak-Rusinek, Karolina Gołąbek, Marek Michalski, Natalia Matysiak, Zenon Czuba

    Glutaredoxin 1 (Grx1) is an essential enzyme that regulates redox signal transduction and repairs protein oxidation by reversing S-glutathionylation, an oxidative modification of protein cysteine residues. Grx1 removes glutathione from proteins to restore their reduced state (protein-SH) and regulate protein-SSG levels in redox signaling networks. Thus, it can exert an influence on the development of cancer. To further investigate this problem, we performed an analysis of Grx1 expression in colon adenocarcinoma samples from the Polish population of patients with primary colon adenocarcinoma (stages I and II of colon cancer) and those with regional lymph node metastasis (stage III of colon cancer). Our study revealed a significant correlation between the expression of Grx1 protein through immunohistochemical analysis and various clinical characteristics of patients, such as histological grade, depth of invasion, angioinvasion, staging, regional lymph node invasion, and PCNA expression. It was found that almost 88% of patients with stage I had high levels of Grx1 expression, while only 1% of patients with stage III exhibited high levels of Grx1 protein expression. Furthermore, the study discovered that high levels of Grx1 expression were present in samples of colon mucosa without any pathological changes. These results were supported by in vitro analysis conducted on colorectal cancer cell lines that corresponded to stages I, II, and III of colorectal cancer, using qRT-PCR and Western blot.


  • Open Access

    Liver Oxidative Status, Serum Lipids Levels after Bariatric Surgery and High-Fat, High-Sugar Diet in Animal Model of Induced Obesity

    by Wojciech Kazura, Katarzyna Michalczyk, Bronisława Skrzep-Poloczek, Elżbieta Chełmecka, Jolanta Zalejska-Fiolka, Marek Michalski, Michał Kukla, Jerzy Jochem, Jakub Rutkowski, Dominika Stygar

    Nutritional status is a major determinant of hepatocyte injuries associated with changed metabolism and oxidative stress. This study aimed to determine the relations between oxidative stress, bariatric surgery, and a high-fat/high-sugar (HFS) diet in a diet-induced obesity rat model. Male rats were maintained on a control diet (CD) or high-fat/high-sugar diet (HFS) inducing obesity. After 8 weeks, the animals underwent SHAM (n = 14) or DJOS (n = 14) surgery and the diet was either changed or unchanged. Eight weeks after the surgeries, the activity of superoxide dismutase isoforms (total SOD, MnSOD, and CuZnSOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and lutathione S-transferase, as well as the thiol groups (-SH) concentration, total antioxidant capacity (TAC), total oxidative stress (TOS) levels, and malondialdehyde (MDA) concentration liver tissue were assessed. The total cholesterol, triglycerides (TG), and high-density lipoprotein (HDL) concentrations were measured in the serum. The total SOD and GPX activities were higher in the SHAM-operated rats than in the DJOS-operated rats. The MnSOD activity was higher in the HFS/HFS than the CD/CD groups. Higher CuZnSOD, GST, GR activities, -SH, and MDA concentrations in the liver, and the triglyceride and cholesterol concentrations in the serum were observed in the SHAM-operated rats than in the DJOS-operated rats. The CAT activity was significantly higher in the HFS-fed rats. Lower TAC and higher TOS values were observed in the SHAM-operated rats. Unhealthy habits after bariatric surgery may be responsible for treatment failure and establishing an obesity condition with increased oxidative stress.


  • Open Access

    Immunohistochemical Expression of Glutathione Peroxidase-2 (Gpx-2) and Its Clinical Relevance in Colon Adenocarcinoma Patients

    by Marlena Brzozowa-Zasada, Angela Ianaro, Adam Piecuch, Marek Michalski, Natalia Matysiak, Katarzyna Stęplewska

    Glutathione peroxidase 2 (Gpx-2) is a selenoenzyme with antioxidant capabilities that may play a role in cancer development. Hence, we investigated the immunohistochemical expression of Gpx-2 protein in colon adenocarcinoma samples derived from patients with colon adenocarcinoma who did not receive any form of treatment prior to the surgical procedure. The associations between the immunohistochemical expression of Gpx-2 and clinical parameters were analysed using the Chi2 test and Fisher’s exact test. A Kaplan–Meier analysis and the log-rank test were used to verify the relationship between the intensity of Gpx-2 expression and the 5-year survival rate of patients. In total, 101 (80.80%) samples had strong Gpx-2 protein expression and 24 (19.20%) samples were characterized with low expression. The high expression of Gpx-2 was correlated with the histological grade of the tumour (p < 0.001), PCNA immunohistochemical expression (p < 0.001), depth of invasion (p = 0.001) and angioinvasion (p < 0.001). We can conclude that high expression of Gpx-2 is correlated with reduced survival of colon adenocarcinoma patients (log-rank, p < 0.001).


  • Open Access

    Przewodnik do ćwiczeń z histologii : semestr I

    by Marlena Brzozowa-Zasada, Marek Michalski, Łukasz Mielańczyk, Adam Piecuch

  • Open Access

    Immunohistochemical Expression of Upregulated Gene 4 Protein Expression (URG4/URGCP) and Its Association with 5-Year Survival in Patients with Colon Adenocarcinoma

    by Marlena Brzozowa-Zasada, Adam Piecuch, Marek Michalski, Katarzyna Stęplewska, Natalia Matysiak, Marek Kucharzewski

    (1) Background: Colorectal cancer (CRC) is the third most common cancer in terms of incidence and mortality. Approximately 90% of all colorectal cancer cases are adenocarcinomas, originating from epithelial cells of the colorectal mucosa. Upregulated gene 4 (URG4) is an oncogene involved in cancer development. The aim of the study was to assess the immunohistochemical expression of URG4 protein expression in Polish patients with colon adenocarcinoma who were not treated with any therapy before radical surgery. (2) Methods: The study used colon tissue samples taken from people with a confirmed diagnosis of colorectal adenocarcinoma after a thorough histopathological examination. The associations between the immunohistochemical expression of URG4 and clinical parameters were analyzed by the Chi2 test or Chi2Yatesa test. The study conducted an analysis of the correlation between the expression of URG4 and the five-year survival rate of patients through the application of the Kaplan–Meier analysis and the log-rank statistical test. The intracellular localization of URG4 was identified through the utilization of transmission electron microscopy (TEM) methodology. (3) Results: In univariate Cox regression analyses, immuno-histochemical expression of URG4, grade of histological differentiation, depth of invasion, angioinvasion, PCNA expression, stage of disease and lymph node involvement were found to be significant prognostic factors. Within our patient cohort, it was observed that the degree of tumour differentiation and URG4 expression were found to be distinct prognostic factors in regard to the 5-year survival rates of those with colon adenocarcinoma. (4) Conclusions: High immunohistochemical expression of URG4 correlates with poor prognosis in patients with colon adenocarcinoma.


  • Open Access

    Immunohistochemical Expression of Glutathione Peroxidase 1 (Gpx-1) as an Independent Prognostic Factor in Colon Adenocarcinoma Patients

    by Marlena Brzozowa-Zasada, Adam Piecuch, Karolina Bajdak-Rusinek, Kamil Janelt, Marek Michalski, Olesya Klymenko, Natalia Matysiak

    Several studies revealed that expression levels of glutathione peroxidase 1 (Gpx-1) can be associated with cancer development, mainly through its role in hydroperoxide scavenging by regulating intracellular reactive oxygen species (ROS) levels. Therefore, our aim was to investigate the expression of Gpx-1 protein in a population of Polish patients with colon adenocarcinoma in the absence of any therapy prior to radical surgery. The study was carried out using colon tissue from patients with adenocarcinoma of the colon confirmed by histopathological examination. Gpx-1 antibody was used to determine the immunohistochemical expression of Gpx-1. The Chi2test or Chi2Yatesa test were used to analyse the associations between the immunohistochemical expression of Gpx-1 and clinical parameters. The relationship between Gpx-1 expression, and 5-year patient survival was examined using Kaplan–Meier analysis and the log-rank test. Intracellular localisation of Gpx-1 was detected by the use of transmission electron microscopy (TEM). Western blot analysis was used for the evaluation of Gpx-1 protein expression levels in cancer cell lines in vitro. Immunohistochemical study revealed that the high expression of Gpx-1 was associated with the tumour’s histological grade, proliferating cell nuclear antigen (PCNA) immunohistochemical expression, depth of invasion, and angioinvasion (all p < 0.001) (4). The high immunohistochemical expression of Gpx-1 is correlated with poor prognosis of colon adenocarcinoma patients.